We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?
Read MoreHide Full Article
Key Takeaways
BrightSpring generated $144 million of operating cash flow in the second quarter.
BTSG cut leverage to 2.15X and repaid about $300 million of its term loan.
BrightSpring plans to pursue tuck-in deals and adjacent acquisitions with disciplined valuations.
BrightSpring Health Services’ (BTSG - Free Report) balance-sheet progress and cash flow improvement in the second quarter could provide the company with greater capacity to pursue acquisitions and support future growth. BrightSpring generated $144 million of operating cash flow in the second quarter, excluding a one-time cash tax payment of approximately $100 million related to the Community Living transaction. Management now expects approximately $600 million of operating cash flow for 2026, with EBITDA-to-operating-cash conversion of around 70%.
Stronger cash generation has been accompanied by lower leverage. BrightSpring ended June with a 2.15X leverage ratio compared with an adjusted 2.4X level in the first quarter, representing a 0.25X reduction on an adjusted basis.
The company also repaid approximately $300 million of its term loan using proceeds from the Community Living sale and repriced the loan at SOFR plus 200 basis points compared with SOFR plus 325 basis points at the time of its IPO. Moody’s and S&P subsequently upgraded BrightSpring’s credit ratings.
This strengthening financial position appears to be increasing BrightSpring’s strategic flexibility. CFO Jennifer Phipps said the company believes it can continue pursuing M&A and highlighted a robust acquisition pipeline, while CEO Jon Rousseau said BrightSpring is considering expanding its seven-person M&A team. Management expects to remain focused on tuck-in acquisitions and geographically adjacent opportunities where its operating capabilities and synergies can support accretive transactions.
BrightSpring entered the second half of 2026 with improving cash generation, declining leverage and greater capital flexibility. Management specifically indicated that the stronger balance sheet provides flexibility into 2027, although it also emphasized disciplined valuation and deal selection.
Peer Updates
Ensign Group (ENSG - Free Report) continues to make acquisitions a part of its growth strategy, adding 20 operations during and after the quarter and reaching 71 acquired operations since 2025. Management said the pipeline remains active, with opportunities spanning multi-facility portfolios, nonprofits, landlords and smaller transactions, while prioritizing existing markets and selective new states. Ensign’s acquisition model targets assets with operational and clinical improvement potential, supported by local leadership and cluster resources.
Funding capacity appears strong as the company had $262.3 million of cash and more than $592 million available under its credit line as of the end of the second quarter, providing more than $850 million of combined liquidity for future investments.
Although Encompass Health (EHC - Free Report) is not focused on M&A, management views de novo hospital development and joint ventures as key growth levers. The company opened three hospitals with 139 beds and plans five more totaling 250 beds, while its pipeline includes 13 hospitals and 606 beds beyond 2026.
North Carolina offers expansion potential following repeal of its Certificate of Need law. On funding, EHC ended the second quarter with 1.9X net leverage and said leverage and liquidity remained well positioned. The company issued $500 million of senior notes, using most of the proceeds to redeem $400 million of existing debt.
BTSG’s Price Performance, Valuation and Estimates
Shares of BTSG have surged 49.6% year to date compared with the industry’s 3.3% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, BrightSpring Health Services trades at a forward price-to-earnings of 26.12X, above the industry average. It is also trading higher than its three-year median of 22.15X. BTSG carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BrightSpring Health Services’ 2026 earnings implies an 82% rise from the year-ago period’s level.
View the Zacks #1 Rank List
Image: Bigstock
Will M&A Be the Next Growth Factor as BTSG's Cash Flow and Leverage Improve?
Key Takeaways
BrightSpring Health Services’ (BTSG - Free Report) balance-sheet progress and cash flow improvement in the second quarter could provide the company with greater capacity to pursue acquisitions and support future growth. BrightSpring generated $144 million of operating cash flow in the second quarter, excluding a one-time cash tax payment of approximately $100 million related to the Community Living transaction. Management now expects approximately $600 million of operating cash flow for 2026, with EBITDA-to-operating-cash conversion of around 70%.
Stronger cash generation has been accompanied by lower leverage. BrightSpring ended June with a 2.15X leverage ratio compared with an adjusted 2.4X level in the first quarter, representing a 0.25X reduction on an adjusted basis.
The company also repaid approximately $300 million of its term loan using proceeds from the Community Living sale and repriced the loan at SOFR plus 200 basis points compared with SOFR plus 325 basis points at the time of its IPO. Moody’s and S&P subsequently upgraded BrightSpring’s credit ratings.
This strengthening financial position appears to be increasing BrightSpring’s strategic flexibility. CFO Jennifer Phipps said the company believes it can continue pursuing M&A and highlighted a robust acquisition pipeline, while CEO Jon Rousseau said BrightSpring is considering expanding its seven-person M&A team. Management expects to remain focused on tuck-in acquisitions and geographically adjacent opportunities where its operating capabilities and synergies can support accretive transactions.
BrightSpring entered the second half of 2026 with improving cash generation, declining leverage and greater capital flexibility. Management specifically indicated that the stronger balance sheet provides flexibility into 2027, although it also emphasized disciplined valuation and deal selection.
Peer Updates
Ensign Group (ENSG - Free Report) continues to make acquisitions a part of its growth strategy, adding 20 operations during and after the quarter and reaching 71 acquired operations since 2025. Management said the pipeline remains active, with opportunities spanning multi-facility portfolios, nonprofits, landlords and smaller transactions, while prioritizing existing markets and selective new states. Ensign’s acquisition model targets assets with operational and clinical improvement potential, supported by local leadership and cluster resources.
Funding capacity appears strong as the company had $262.3 million of cash and more than $592 million available under its credit line as of the end of the second quarter, providing more than $850 million of combined liquidity for future investments.
Although Encompass Health (EHC - Free Report) is not focused on M&A, management views de novo hospital development and joint ventures as key growth levers. The company opened three hospitals with 139 beds and plans five more totaling 250 beds, while its pipeline includes 13 hospitals and 606 beds beyond 2026.
North Carolina offers expansion potential following repeal of its Certificate of Need law. On funding, EHC ended the second quarter with 1.9X net leverage and said leverage and liquidity remained well positioned. The company issued $500 million of senior notes, using most of the proceeds to redeem $400 million of existing debt.
BTSG’s Price Performance, Valuation and Estimates
Shares of BTSG have surged 49.6% year to date compared with the industry’s 3.3% growth.
Image Source: Zacks Investment Research
From a valuation standpoint, BrightSpring Health Services trades at a forward price-to-earnings of 26.12X, above the industry average. It is also trading higher than its three-year median of 22.15X. BTSG carries a Value Score of B.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for BrightSpring Health Services’ 2026 earnings implies an 82% rise from the year-ago period’s level.
Image Source: Zacks Investment Research
The company currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.